The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo
- Publication type:
- Journal article
- Metadata:
-
- Autoren
- SJF Kaptein
- T Efferth
- M Leis
- S Rechter
- S Auerochs
- M Kalmer
- CA Bruggeman
- C Vink
- TA Stamminger
- M Marschall
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:000235418100002&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.1016/j.antiviral.2005.10.003
- eISSN
- 1872-9096
- Externe Identifier
- Clarivate Analytics Document Solution ID: 013OH
- PubMed Identifier: 16325931
- ISSN
- 0166-3542
- Ausgabe der Veröffentlichung
- 2
- Zeitschrift
- ANTIVIRAL RESEARCH
- Schlüsselwörter
- cytomegalovirus
- drug development
- artesunate
- ferrous irons
- combined antiviral therapy
- Paginierung
- 60 - 69
- Datum der Veröffentlichung
- 2006
- Status
- Published
- Titel
- The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo
- Sub types
- Article
- Ausgabe der Zeitschrift
- 69
Data source: Web of Science (Lite)
- Other metadata sources:
-
- Autoren
- S KAPTEIN
- T EFFERTH
- M LEIS
- S RECHTER
- S AUEROCHS
- M KALMER
- C BRUGGEMAN
- C VINK
- T STAMMINGER
- M MARSCHALL
- DOI
- 10.1016/j.antiviral.2005.10.003
- ISSN
- 0166-3542
- Ausgabe der Veröffentlichung
- 2
- Zeitschrift
- Antiviral Research
- Sprache
- en
- Paginierung
- 60 - 69
- Datum der Veröffentlichung
- 2006
- Status
- Published
- Herausgeber
- Elsevier BV
- Herausgeber URL
- http://dx.doi.org/10.1016/j.antiviral.2005.10.003
- Datum der Datenerfassung
- 2019
- Titel
- The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo
- Ausgabe der Zeitschrift
- 69
Data source: Crossref
- Abstract
- Treatment of human cytomegalovirus (HCMV) infections with any of the currently available antiviral agents is frequently associated with the occurrence of severe complications, seriously threatening the successful outcome of treatment. Therefore, the development of novel antiviral strategies is a challenging goal of current investigations. Previously, we reported that artesunate (ART) is an effective, non-cytotoxic inhibitor of HCMV in vitro. Here, we demonstrate that the efficacy of the antiviral effect of ART is augmented by co-treatment of HCMV-infected fibroblasts with ferrous iron, i.e. Ferrosanol, and/or the iron transfer-mediating molecule holo-transferrin. This could alleviate the HCMV-induced modulation of cell surface expression of adhesion molecule Thy-1, suggesting that ART might be able to prevent pro-inflammatory effects of infection. The iron-enhanced, antiviral effect of ART could also be demonstrated in cultured cells infected with rat cytomegalovirus. Experiments using the RCMV/rat model showed that both the viral DNA load and virus titers in the salivary glands from infected rats were significantly reduced upon treatment with ART. Furthermore, an additive antiviral effect for ART together with each one of conventional anti-HCMV drugs, i.e. ganciclovir, cidofovir or foscarnet, was detected in HCMV-infected fibroblasts. These findings might open new perspectives regarding the use of ART in clinical trials.
- Addresses
- Department of Medical Microbiology, University Hospital Maastricht, Maastricht, The Netherlands.
- Autoren
- Suzanne JF Kaptein
- Thomas Efferth
- Thomas Efferth
- Martina Leis
- Sabine Rechter
- Sabrina Auerochs
- Martina Kalmer
- Cathrien A Bruggeman
- Cornelis Vink
- Thomas Stamminger
- Manfred Marschall
- DOI
- 10.1016/j.antiviral.2005.10.003
- eISSN
- 1872-9096
- Externe Identifier
- PubMed Identifier: 16325931
- Open access
- false
- ISSN
- 0166-3542
- Ausgabe der Veröffentlichung
- 2
- Zeitschrift
- Antiviral research
- Schlüsselwörter
- Cells, Cultured
- Fibroblasts
- Animals
- Rats, Inbred Lew
- Humans
- Rats
- Cytomegalovirus
- Muromegalovirus
- Herpesviridae Infections
- Cytomegalovirus Infections
- Ferrous Compounds
- Sesquiterpenes
- Artemisinins
- Transferrin
- Antimalarials
- Antiviral Agents
- Drug Therapy, Combination
- Specific Pathogen-Free Organisms
- Virus Replication
- Immunocompromised Host
- Male
- Artesunate
- Sprache
- eng
- Medium
- Print-Electronic
- Online publication date
- 2005
- Paginierung
- 60 - 69
- Datum der Veröffentlichung
- 2006
- Status
- Published
- Datum der Datenerfassung
- 2005
- Titel
- The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
- Sub types
- Research Support, Non-U.S. Gov't
- Journal Article
- Ausgabe der Zeitschrift
- 69
Data source: Europe PubMed Central
- Abstract
- Treatment of human cytomegalovirus (HCMV) infections with any of the currently available antiviral agents is frequently associated with the occurrence of severe complications, seriously threatening the successful outcome of treatment. Therefore, the development of novel antiviral strategies is a challenging goal of current investigations. Previously, we reported that artesunate (ART) is an effective, non-cytotoxic inhibitor of HCMV in vitro. Here, we demonstrate that the efficacy of the antiviral effect of ART is augmented by co-treatment of HCMV-infected fibroblasts with ferrous iron, i.e. Ferrosanol, and/or the iron transfer-mediating molecule holo-transferrin. This could alleviate the HCMV-induced modulation of cell surface expression of adhesion molecule Thy-1, suggesting that ART might be able to prevent pro-inflammatory effects of infection. The iron-enhanced, antiviral effect of ART could also be demonstrated in cultured cells infected with rat cytomegalovirus. Experiments using the RCMV/rat model showed that both the viral DNA load and virus titers in the salivary glands from infected rats were significantly reduced upon treatment with ART. Furthermore, an additive antiviral effect for ART together with each one of conventional anti-HCMV drugs, i.e. ganciclovir, cidofovir or foscarnet, was detected in HCMV-infected fibroblasts. These findings might open new perspectives regarding the use of ART in clinical trials.
- Date of acceptance
- 2005
- Autoren
- Suzanne JF Kaptein
- Thomas Efferth
- Martina Leis
- Sabine Rechter
- Sabrina Auerochs
- Martina Kalmer
- Cathrien A Bruggeman
- Cornelis Vink
- Thomas Stamminger
- Manfred Marschall
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/16325931
- DOI
- 10.1016/j.antiviral.2005.10.003
- ISSN
- 0166-3542
- Ausgabe der Veröffentlichung
- 2
- Zeitschrift
- Antiviral Res
- Schlüsselwörter
- Animals
- Antimalarials
- Antiviral Agents
- Artemisinins
- Artesunate
- Cells, Cultured
- Cytomegalovirus
- Cytomegalovirus Infections
- Drug Therapy, Combination
- Ferrous Compounds
- Fibroblasts
- Herpesviridae Infections
- Humans
- Immunocompromised Host
- Male
- Muromegalovirus
- Rats
- Rats, Inbred Lew
- Sesquiterpenes
- Specific Pathogen-Free Organisms
- Transferrin
- Virus Replication
- Sprache
- eng
- Country
- Netherlands
- Paginierung
- 60 - 69
- PII
- S0166-3542(05)00228-7
- Datum der Veröffentlichung
- 2006
- Status
- Published
- Datum, an dem der Datensatz öffentlich gemacht wurde
- 2006
- Titel
- The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
- Sub types
- Journal Article
- Research Support, Non-U.S. Gov't
- Ausgabe der Zeitschrift
- 69
Data source: PubMed
- Beziehungen:
- Property of